The coronavirus vaccine developed by Pfizer and BioNTech is more than 90 percent effective, the companies said Monday in a major milestone for the fight against the deadly global pandemic.
The Manhattan-based drugmaker and the German biotech firm became the first pharmaceutical outfits to reveal successful data from a large, late-stage study of a COVID-19 vaccine at a time when the US and other nations are grappling with surging infection counts.
“Today is a great day for science and humanity,” Pfizer CEO Albert Bourla said in a statement. “With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis.”
This data comes from their Phase 3 study.
Pfizer Inc. teamed up with BioNTech SE, and they announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection.
Without Trump easing regulations and forming business-government partnerships, none of this would have happened.
Do you notice that they waited until a week after the election to make the announcement? They didn’t know this last week or two weeks ago?
You can comment on the article after the ads and subscribe to the Daily Newsletter here if you would like a quick view of the articles of the day and any late news: